Device tested in humans for first time, raising prospect of ‘fit and forget’ treatment

An implant containing an HIV-prevention drug has been trialled in humans, in a step experts have hailed as an exciting development in curtailing infections.

Pre-exposure prophylaxis, or PrEP, with antiretroviral drugs has become a hot topic in recent years, with the drugs shown to substantially reduce the risk of contracting HIV from an HIV-positive partner. PrEP pills are already available through the NHS in Scotland to high-risk individuals, while trials are under way in England.

Continue reading…

Read More Trial of HIV prevention implant hailed as boost in fight against disease

Facebook Comments